Nutraceutical Intl (NUTR) 25.62 $NUTR Nutraceutical

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Nutraceutical Intl (NUTR) 25.62 $NUTR

Nutraceutical Reports Fiscal 2016 Q3 Results And Expands Share Repurchase Program
PR Newswire - Thu Jul 28, 6:00AM CDT
Nutraceutical International Corporation (NASDAQ: NUTR) today reported results for the fiscal 2016 third quarter ended June 30, 2016. Net sales for the fiscal 2016 third quarter were $60.8 million, compared to $54.4 million for the same quarter of fiscal 2015. For the third quarter of fiscal 2016, net income was $6.0 million, or $0.65 diluted earnings per share, compared to net income of $4.5 million, or $0.47 diluted earnings per share, for the same quarter of fiscal 2015.
NUTR: 25.62 (+0.02)

Nutraceutical posts 2Q profit
Automated Insights - Thu Apr 28, 8:48AM CDT
PARK CITY, Utah (AP) _ Nutraceutical International Corp. (NUTR) on Thursday reported fiscal second-quarter net income of $4.6 million.
NUTR: 25.62 (+0.02)

Nutraceutical Reports Fiscal 2016 Q2 Results
PR Newswire - Thu Apr 28, 6:00AM CDT
Nutraceutical International Corporation (NASDAQ: NUTR) today reported results for the fiscal 2016 second quarter ended March 31, 2016. Net sales for the fiscal 2016 second quarter were $59.5 million, compared to $55.4 million for the same quarter of fiscal 2015. For the second quarter of fiscal 2016, net income was $4.6 million, or $0.49 diluted earnings per share, compared to net income of $4.1 million, or $0.43 diluted earnings per share, for the same quarter of fiscal 2015.
NUTR: 25.62 (+0.02)

Identifying Opportunity in Market Momentum - Research on Heritage-Crystal Clean, T2 Biosystems, Nutraceutical International and Cambium Learning Group
ACCESSWIRE - Mon Dec 07, 7:01AM CST
NEW YORK, NY / ACCESSWIRE / December 7, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Heritage-Crystal Clean Inc. (NASDAQ: HCCI), T2 Biosystems Inc. (NASDAQ: TTOO), Nutraceutical International Corp. (NASDAQ: NUTR) and Cambium Learning Group Inc. (NASDAQ: ABCD). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
TTOO: 6.72 (+0.01), NUTR: 25.62 (+0.02), ABCD: 4.70 (+0.01), HCCI: 13.16 (-0.19)

What's Driving the Equity Prices - Research on Heritage-Crystal Clean, T2 Biosystems, Nutraceutical International, and Cambium Learning Group
ACCESSWIRE - Fri Nov 27, 6:55AM CST
NEW YORK, NY / ACCESSWIRE / November 27, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Heritage-Crystal Clean Inc. (NASDAQ: HCCI), T2 Biosystems Inc. (NASDAQ: TTOO), Nutraceutical International Corp. (NASDAQ: NUTR) and Cambium Learning Group Inc. (NASDAQ: ABCD). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
TTOO: 6.72 (+0.01), NUTR: 25.62 (+0.02), ABCD: 4.70 (+0.01), HCCI: 13.16 (-0.19)

Nutraceutical Reports Fiscal 2015 Year End Results
PR Newswire - Thu Nov 19, 6:00AM CST
Nutraceutical International Corporation (NASDAQ: NUTR) today reported results for the fiscal 2015 fourth quarter ended September 30, 2015. Net sales for the fiscal 2015 fourth quarter were $53.6 million, compared to $52.4 million for the same quarter of fiscal 2014. For the fourth quarter of fiscal 2015, net income was $3.4 million, or $0.35 diluted earnings per share, compared to net income of $3.4 million, or $0.35 diluted earnings per share, for the same quarter of fiscal 2014.
NUTR: 25.62 (+0.02)

Endo International Slumps: ENDP Tanks 10.2% in Session
Zacks Equity Research - Zacks Investment Research - Tue Sep 29, 7:34AM CDT
Endo International (ENDP) fell over 10% in the last trading session amid huge volumes, continuing its recent trend, as the stock is now down nearly 20% in the past one month.
ENDP: 19.82 (-0.41), NUTR: 25.62 (+0.02)

Should You Get Rid of Jazz Pharmaceuticals (JAZZ) Now?
Zacks Equity Research - Zacks Investment Research - Fri Sep 04, 7:50AM CDT
Jazz Pharmaceuticals has an unfavorable Zacks Rank and the stock has been witnessing a significant price decline and negative earnings estimate revisions
JAZZ: 120.84 (-2.47), NUTR: 25.62 (+0.02)

Vitamin Supplements Market Development and Demand Forecast to 2020 - Provides Information on the Historical and Current Market Size and the Future Potential of the Market
M2 - Thu Aug 20, 5:07AM CDT
Research and Markets (http://www.researchandmarkets.com/research/6sjp3h/global_industry) has announced the addition of the "Global Industry Insight: Vitamin Supplements Market Development and Demand Forecast to 2020" report to their offering. The vitamin supplements market in the report includes vitamin supplements that are taken in different forms including capsule, pill, powder, granules, gel caps, tablet and liquid. The report includes the vitamin supplements offered by food and beverage, healthcare and personal care industry and consumed by adult women, adult men and elderly citizen. Global vitamin supplements market is increasing mainly attributed to growing consciousness among consumer about preventative healthcare. Healthcare spend is increasing with the increasing research and development (R&D) expenditure. Due to the increasing cost of healthcare, people are turning towards supplement products, including vitamin supplements, for a healthy life. Rising urban population paired with rise in educational qualification and rising number of health conscious people, especially in the developing Asian countries such as India and China, are more willing to shift towards intake of supplement products including vitamin supplements to compensate their nutritional requirement. Report Coverage: - Provides comprehensive understanding of the market with the help of informed market outlook, opportunities, challenges, trends, size and growth, competitive analysis, major competitors and Porter analysis - Identifies the key drivers of growth and challenges of the key industry players. Also, assesses the future impact of the propellants and restraints on the market - Provides information on the historical and current market size and the future potential of the market Key Topics Covered: 1 Research Scope and Methodology 2 Executive Summary 3 Market Outlook 4 Global Market Size and Forecasts (2010 - 2020) 5 Global Market Breakdown by End-User 6 Global Market Breakdown by Application 7 Global Market Breakdown by Region 8 Competitive Analysis and Market Share 9 Company Profiles Companies Mentioned - Archer Daniels Midland Company - BASF SE - Bayer AG - E.I. du Pont de Nemours and Company - Glanbia plc - Herbalife Ltd. - Integrated BioPharma, Inc - NBTY, Inc. - Nutraceutical International Corporation - Pharmavite LLC - Reckitt Benckiser Group plc - Royal DSM N.V. For more information visit http://www.researchandmarkets.com/research/6s...l_industry
HLF: 61.35 (+0.18), ADM: 43.82 (+0.68), NUTR: 25.62 (+0.02)

Uptrend Call Working As Nutraceutical International Stock Rises 16.1% (NUTR)
Comtex SmarTrend(R) - Tue Aug 18, 5:07PM CDT
SmarTrend identified an Uptrend for Nutraceutical International (NASDAQ:NUTR) on May 21st, 2015 at $20.53. In approximately 3 months, Nutraceutical International has returned 16.05% as of today's recent price of $23.82.
NUTR: 25.62 (+0.02)

17.4% Return Seen to Date on SmarTrend Nutraceutical International Call (NUTR)
Comtex SmarTrend(R) - Tue Jul 21, 10:32AM CDT
SmarTrend identified an Uptrend for Nutraceutical International (NASDAQ:NUTR) on May 21st, 2015 at $20.53. In approximately 2 months, Nutraceutical International has returned 17.37% as of today's recent price of $24.09.
NUTR: 25.62 (+0.02)

Nutraceutical International Shares Up 18.8% Since SmarTrend's Buy Recommendation (NUTR)
Comtex SmarTrend(R) - Mon Jul 13, 5:27PM CDT
SmarTrend identified an Uptrend for Nutraceutical International (NASDAQ:NUTR) on May 21st, 2015 at $20.53. In approximately 2 months, Nutraceutical International has returned 18.83% as of today's recent price of $24.39.
NUTR: 25.62 (+0.02)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 363

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 387

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 544

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
Bloomberg, HKEX Expand Offshore RMB Bond Indices

Updated Category News Views 109

A Move to Elevate Dim Sum Bonds If you're wondering what's cooking in the bond market arena, Bloomberg and HKEX just turned up the heat with a new family of RMB bond indices. These aren't just any run-of-the-mill indices; they're targeting the offshore RMB market, affectionately called the Dim Sum bond market. For those of us grizzled vets in the trading world, this is...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 305

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Thunes Boosts Bhutan Remittances with Instant Payments

Updated Category News Views 161

Thunes' Network Expands to Bhutan: A Game Changer I'll say one thing clear—Thunes isn't messing around. They've just opened the gates for real-time payouts to Bhutan, and it's going to be a game-changer for those living abroad who want to send money back home. Look, for years, Non-Resident Bhutanese have been diving into hoops just to get their bucks across borders....

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 380

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 411

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 174

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 277

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading

Top 5 Most Recently Viewed Articles

Roche Unveils High-Sensitivity Troponin T Test Increasing Diagnosis Precision

Updated Category News Views 350

The Unveiling of Roche's Sixth-Generation Troponin T Test Roche has recently been granted a CE Mark for its innovative sixth-generation Troponin T test, which promises to deliver a new level of accuracy that is critical for diagnosing heart attacks. This novel testing solution is designed to enhance sensitivity and precision, allowing for quicker and more reliable...

Continue Reading
Maximize Your Earnings with Keurig Dr Pepper Stock Strategy

Updated Category News Views 133

Understanding Keurig Dr Pepper's Earnings Potential Keurig Dr Pepper Inc. (NASDAQ: KDP) is preparing to share its third quarter earnings results shortly. Investors eagerly await the disclosures, which are expected to highlight positive financial trends and growth. Analysts predict that the company will report earnings per share of 54 cents, an increase from 51 cents in...

Continue Reading
Uwharrie Capital Corp Celebrates Year-End Financial Growth

Updated Category News Views 113

Uwharrie Capital Corp Reports Strong Year-End Results Uwharrie Capital Corp and its subsidiary, Uwharrie Bank, have recently unveiled impressive financial results that reflect their continued strength and stability in the banking sector. The company reported consolidated total assets of $1.13 billion at the end of the reporting period, demonstrating a noticeable increase...

Continue Reading
Enhancing California's Tourism Appeal with Interactive Design

Updated Category News Views 148

Revolutionizing Tourism Through Interactive Web Design In today's fast-paced digital world, engaging younger travellers has become crucial for tourism boards in California. Digital Silk, an award-winning agency renowned for its expertise in digital marketing and web design, is leading the charge to inspire Generation Z and millennials by advocating for the adoption of...

Continue Reading
FOX News Digital Dominates October with Record-Breaking View Counts

Updated Category News Views 174

FOX News Digital Achieves Historic Success in October Leading YouTube with 377 Million Video Views During the month of October, FOX News Digital achieved outstanding milestones, topping the charts in multiplatform engagement. With a staggering 3.7 billion multiplatform minutes and 1.8 billion views, the platform outshined its competitors, establishing its dominance in the...

Continue Reading